Clinical Trial Update: Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

View source ↗

Summary

This clinical trial update describes a study investigating determinants of response to BTK degraders in chronic lymphocytic leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• BTK Degraders (BTK degrader)

Snippet

Sponsor: Nantes University Hospital | Conditions: Chronic Lymphocytic Leukemia, BTK Degraders | Status: RECRUITING